Biotech

All Articles

Sanofi's $80M bank on Fulcrum dystrophy medicine ends in period 3 lose big

.Simply 4 months after Sanofi bet $80 thousand in beforehand cash money on Key Therapies' losmapimod...

Oncternal stock sinks 60% amid discharges, test terminations

.Cancer provider Oncternal Therapeutics is actually folding all its medical tests as well as giving ...

Roche is actually carrying out chances that its own injectable excessive weight prospect could ultimately show 25% weight-loss in late-stage trial

.Roche is actually holding out hopes that its injectable being overweight possibility can eventually...

Novo Nordisk hails 'outstanding' fat loss result for dual-acting oral medication in very early trial

.Novo Nordisk has actually elevated the top on a stage 1 trial of its dental amylin as well as GLP-1...

AbbVie files a claim against BeiGene over blood cancer drug trade secrets

.Just a few quick full weeks after gaining an FDA Fast Track tag for its own investigational BTK deg...

Lilly provides one-two strike with second tranche of favorable records on regular insulin candidate

.Soon after a favorable records decrease for Eli Lilly's efsitora alfa, the Indianapolis-based provi...

BridgeBio reduces gene treatment spending plan as medical information dissatisfy

.BridgeBio Pharma is actually lowering its gene therapy spending plan as well as pulling back coming...

GSK surrenders HSV vaccination wishes after stage 2 fail, ceding ethnicity to Moderna, BioNTech

.GSK's attempt to build the initial vaccination for herpes simplex virus (HSV) has ended in failure,...

GSK's long-acting breathing problem medication halved assaults in phase 3

.GSK's long-acting asthma therapy has been actually shown to cut in half the variety of attacks in a...

AstraZeneca, Daiichi unbox Dato-DXd's total survival fail

.AstraZeneca and Daiichi Sankyo's TROP2-directed antibody-drug conjugate (ADC) has neglected to stre...